TNNI3 and rheumatoid arthritis: The most plausible explanation is that elevated hs-cTn-I concentrations in RA patients reflect subclinical myocardial damage, perhaps reflected by small vessel disease or fibrosis, in addition to that accrued from hypertension, age, and other cardiovascular risk factors.